Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

October 15, 2010 (Vol. 30, No. 18)

Stem Cell Therapies Make Steady Progress

Preclinical Development of ESC-, iPSC-, CSC-, and CLSC-Derived Products Moves Along Briskly

  • Stem cells are many things to many people—a product of an errant procedure, the origin of cancer, a naturally occurring source of unlimited healing potential, a Frankenstein-like creation of virally infected cells, or a political football. CHI’s inaugural “Stem Cells in Drug Discovery and Development,” to be held ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.